No Data
No Data
Minimally Invasive Healthcare (00853) reported 2023 annual results, and losses attributable to shareholders increased 9.4% year-on-year to US$478 million
Minimally Invasive Healthcare (00853) announced its annual results for the year ended December 31, 2023. The company's revenue was 9...
MICROPORT: ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2023
J.P. Morgan sells 11.182,500 common shares of Minimally Invasive Healthcare (00853.HK) worth approximately HK$74.35 million
On March 28, it was reported that according to documents disclosed by the Hong Kong Stock Exchange on March 28, JPMorgan Chase & Co. (JPMorgan Chase & Co.) sold $11.182,500 common shares worth approximately HK$74.35 million on March 25 at an average price of HK$6.6488 per share and an average OTC average price of HK$6.6344 per share. After the sale, J.P. Morgan Chase's latest shareholding was 253 million shares, and the good position ratio dropped from 14.41% to 13.80%. Image source: Stock Exchange equity disclosure What is equity
Minimally Invasive Healthcare (00853): Cardiac Medical Technology's net profit to the mother in 2023 was 492 million yuan, up 37.98% year-on-year
Minimally Invasive Healthcare (00853) released Affiliated Cardiac Medical Technology, which has been reviewed for 12 months ending December 31, 2023...
MICROPORT: FURTHER UPDATE ON THE ESTIMATED ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2023
Changes in Hong Kong stocks | Minimally Invasive Healthcare (00853) falls more than 4%, and the expected annual loss is no more than US$650 million. Institutions say the performance forecast is lower than expected
Minimally Invasive Medicine (00853) fell by more than 4%. As of press release, it fell 4.26% to HK$6.29 million, with a turnover of HK$35.99 million.
No Data